骨髓移植

预约门诊
打印

科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业，通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

研究

妙佑医疗国际的科学家正在积极研究改善骨髓移植预后的相关方法。研究领域包括：

  • 扩展单倍体相合骨髓移植的应用范围
  • 寻找使用骨髓移植的新方法，包括小儿血红蛋白病和遗传性代谢病
  • 改善骨髓移植幸存者的生活质量
  • 预防和应对移植物抗宿主病（GVHD）
  • 了解慢性 GVHD

了解更多关于骨髓移植项目的相关研究。

癌症研究系与妙佑医疗国际综合癌症中心合作开展。癌症中心获得美国国家癌症研究所的资助，是指定的综合癌症中心 — 这是对其致力于癌症预防、诊断和治疗的卓越科学成就和多学科资源的认可。

文献

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在骨髓移植领域的文献著述列表。

Research Profiles

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

申请预约
关于在 Mayo Clinic 治疗
March 28, 2024
打印
  1. AskMayoExpert. Hematopoietic stem cell transplant. Mayo Clinic; 2020.
  2. Hoffman R, et al. Overview and choice of donor of hematopoietic stem cell transplantation. In: Hematology: Basic Principles and Practice. 7th ed. Elsevier; 2018. https://www.clinicalkey.com. Accessed Jan. 28, 2022.
  3. Blood-forming stem cell transplants. National Cancer Institute. http://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/stem-cell-fact-sheet. Accessed Jan. 28, 2022.
  4. Majhail NS. How to perform hematopoietic stem cell transplantation. JACC CardioOncology. 2021; doi:10.1016/j.jaccao.2021.09.012.
  5. Diseases treatable by transplants. National Marrow Donor Program. https://bethematch.org/transplant-basics/how-transplants-work/diseases-treatable-by-transplants/. Accessed Jan. 27, 2022.
  6. AskMayoExpert. Cutaneous graft-versus-host disease (adult). Mayo Clinic; 2021.
  7. Blood and marrow stem cell transplantation. Leukemia & Lymphoma Society. https://www.lls.org/resource-center/download-or-order-free-publications. Accessed Jan. 28, 2022.
  8. Chao NJ. Survival, quality-of-life and late complications after hematopoietic cell transplantation in adults. https://www.uptodate.com/contents/search. Accessed Feb. 10, 2022.
  9. Blood and bone marrow transplant. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/blood-and-bone-marrow-transplant. Accessed Jan. 28, 2022.
  10. D'Souza A, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biology of Blood and Marrow Transplantation. 2020; doi:10.1016/j.bbmt.2020.04.013.
  11. Hematopoietic stem cell transplantation. Merck Manual Professional Version. https://www.merckmanuals.com/professional/immunology-allergic-disorders/transplantation/hematopoietic-stem-cell-transplantation#. Accessed Feb. 10, 2022.
  12. Blood and marrow transplant (BMT): An introduction to allogeneic BMT. Leukemia & Lymphoma Society. https://www.lls.org/resource-center/download-or-order-free-publications. Accessed Jan. 28, 2022.
  13. Participating clinical centers. Primary Immune Deficiency Treatment Consortium. https://www.rarediseasesnetwork.org/cms/pidtc/Learn-More/Participating-Clinical-Centers. Accessed Feb. 18, 2022.
  14. Full membership institutions. Pediatric Transplantation and Cellular Therapy Consortium. http://www.pbmtc.org/about/members/full. Accessed Feb. 18, 2022.
  15. Participating institutions. ECOG-ACRIN Cancer Research Group. https://ecog-acrin.org/participating-institutions. Accessed Feb. 18, 2022.
  16. Mills SD, et al. Bone-marrow transplant in an identical twin. JAMA. 1964; doi:10.1001/jama.1964.03060380005001.
  17. Rashidi A, et al. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Advances. 2019; doi:10.1182/bloodadvances.2019000050.
  18. Ahmed S, et al. Lower graft-versus-host disease and relapse risk in post-transplant cyclophosphamide-based haploidentical versus matched sibling donor reduced-intensity conditioning transplant for Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2019.05.025.
  19. Jain T, et al. Choosing a reduced-intensity conditioning regimen for allogeneic stem cell transplantation, fludarabine/busulfan versus fludarabine melphalan: A systematic review and meta-analysis. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2018.11.016.
  20. Chen YB, et al. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. Blood Advances. 2019; doi:10.1182/bloodadvances.2018027599.
  21. Ballen KK, et al. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: Comparison among alternative graft sources. Biology of Blood and Marrow Transplantation. 2014; doi:10.1016/j.bbmt.2014.07.021.
  22. Sweeney SK, et al. Tracking embryonic hematopoietic stem cells to the bone marrow: Nanoparticle options to evaluate transplantation efficiency. Stem Cell Research & Therapy. 2018; doi:10.1186/s13287-018-0944-8.
  23. Kumar A, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis: An updated systematic review and meta-analysis. Bone Marrow Transplantation. 2019; doi:10.1038/s41409-018-0393-0.
  24. Graff TM, et al. Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Bone Marrow Transplant. 2015; doi:10.1038/bmt.2015.46.
  25. Braswell Pickering EA. Allscripts EPSi. Mayo Clinic. March 1, 2022.
  26. Search for a FACT accredited organization. Foundation for the Accreditation of Cellular Therapy (FACT). http://accredited.factwebsite.org/. Accessed Feb. 18, 2022.
  27. Transplant center search results. Be The Match. https://bethematch.org/tcdirectory/search/advanced/#mayo/-/-/false/-. Accessed Feb. 18, 2022.
  28. Participating transplant centers. Center for International Blood and Marrow Transplant Research. https://www.cibmtr.org/About/WhoWeAre/Centers/Pages/index.aspx?country=us&state=Minnesota. Accessed Feb. 18, 2022.
  29. Locations. Children's Oncology Group. https://childrensoncologygroup.org/index.php/locations/. Accessed Feb. 18, 2022.

相关

Mayo Clinic 新闻

产品与服务

妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际佛罗里达州杰克逊维尔院区和妙佑医疗国际亚利桑那州凤凰城/斯科茨代尔院区均在《美国新闻与世界报道》2024-2025 全美最佳癌症医院评选中名列前茅。

了解更多关于这一最高荣誉的信息

骨髓移植